Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML Susmita Roy17 Aug 2025 4:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...
Sun Pharma Gets SEC Nod to Conduct Phase III Trial of Resmetirom Tablets Dr. Divya Colin17 Aug 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended allowing Sun...
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 Strengths Parthika Patel15 Aug 2025 3:02 PM ISTNew Delhi: Lupin Limited has received the green light from the Subject Expert Committee (SEC) under the Endocrinology & Metabolism division of the...
Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride Tablets Susmita Roy15 Aug 2025 2:31 PM ISTNew Delhi: Sun Pharma Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
Setback to Torrent: CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps Susmita Roy14 Aug 2025 9:28 PM ISTNew Delhi: Citing that Torrent Pharmaceuticals has not presented adequate safety data on the synergistic effect of added excipients (propylene glycol,...
CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug Imports Parthika Patel13 Aug 2025 6:07 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has introduced a new online Dual Use No Objection Certificate (NOC) system on its...
Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management Susmita Roy13 Aug 2025 5:39 PM ISTNew Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Sun Pharma's Phase IV Study on Dual Release Pantoprazole for GERD Gets CDSCO Panel Acceptance Dr. Divya Colin12 Aug 2025 1:46 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the results of Sun Pharma's...
Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection Susmita Roy12 Aug 2025 12:47 PM ISTNew Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
CDSCO Cancels Cosmetic Import Registration of Indian Agent for Proteos Biotech Parthika Patel11 Aug 2025 3:45 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has cancelled the Cosmetic Registration Certificate No. RC/COS-003595, held by NKG...
No More Physical WHO-GMP Certificate Applications After August 15: DCGI Alerts Pharma Firms Susmita Roy11 Aug 2025 5:45 AM ISTNew Delhi: Reaffirming that no further extensions will be granted, the Drugs Controller General of India (DCGI), Central Drugs Standard Control...
CDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data Parthika Patel10 Aug 2025 1:00 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs...
